Enzalutamide - CanMED: HCPCS

Return Home

Home

SEER Data & Software

Observational Research in Oncology Toolbox

Medication Information

CanMED: HCPCS

Generic Name:

Enzalutamide

Brand Name:

Xtandi

Strength:

40 mg

HCPCS:

NA

SEER*Rx Category:

Hormonal Therapy

Major Drug Class:

Androgen Receptor Inhibitor

Minor Drug Class:

Oral (Y/N):

Yes

FDA Approval Year:

2012

FDA Discontinuation Year:

CMS Effective Date:

CMS Discontinuation Date:

Status:

In Use